low dose naltrexone / Weight Cancer Research Results

LDN, low dose naltrexone: Click to Expand ⟱
Features:
Naltrexone is a medication primarily used to treat opioid addiction and alcohol dependence. Some studies suggest that low-dose naltrexone (LDN) may have anti-cancer properties.
LDN has been shown to inhibit the growth of certain types of cancer cells, including breast, lung, and colon cancer cells, in laboratory studies.
Weight, Weight: Click to Expand ⟱
Source:
Type:
Weight
Scientific Papers found: Click to Expand⟱
271- ALA,  VitC,  LDN,    The Long-Term Survival of a Patient With Stage IV Renal Cell Carcinoma Following an Integrative Treatment Approach Including the Intravenous α-Lipoic Acid/Low-Dose Naltrexone Protocol
OS↑, Weight↑, TumVol↓,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Functional Outcomes ⓘ

OS↑, 1,   TumVol↓, 1,   Weight↑, 1,  
Total Targets: 3

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: Weight, Weight
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:198  Target#:603  State#:%  Dir#:2
  wNotes=0  sortOrder:rid,rpid

 

Home Page